TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32127424

Group type: EXPERIMENTAL
Intervention: Curved rubber bristle interdental cleaner (cRBIC)
Number of subjects: 50

Group type: COMPARATOR
Intervention: ADA-accepted dental floss (Floss)
Number of subjects: 50
Study: 33892613

Group type: EXPERIMENTAL
Intervention: Stress management training
Number of subjects: 206

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 206
Study: 34032691

Group type: EXPERIMENTAL
Intervention: ED-based nursing intervention
Number of subjects: 200

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 200
Study: 32986462

Group type: EXPERIMENTAL
Intervention: Self-questionnaire (aRSD) assessing suicide risk in the 15 preceding days
Number of subjects: 827

Group type: EXPERIMENTAL
Intervention: Self-questionnaire (aRSD) assessing suicide risk in the context of psychiatric consultation
Number of subjects: 827
Study: 34357527

Group type: EXPERIMENTAL
Intervention: Video exercise–based telerehabilitation software (Fizyoweb)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional rehabilitation (paper-based exercise instruction form)
Number of subjects: 50
Study: 32804408

Group type: EXPERIMENTAL
Intervention: Daratumumab-lenalidomide-dexamethasone (D-Rd)
Number of subjects: 0
Study: 34802113

Group type: EXPERIMENTAL
Intervention: LLETZ-VC
Number of subjects: 218
Study: 33650930

Group type: EXPERIMENTAL
Intervention: 4 mg ondansetron
Number of subjects: 194

Group type: COMPARATOR
Intervention: 4 mg ondansetron plus 8 mg dexamethasone
Number of subjects: 194
Study: 32234902

Group type: EXPERIMENTAL
Intervention: Bevacizumab plus platinum-based chemotherapy
Number of subjects: 58

Group type: COMPARATOR
Intervention: Erlotinib
Number of subjects: 58
Study: 34696966

Group type: EXPERIMENTAL
Intervention: Bilateral ultrasound-guided pectointercostal fascial block (PIFB)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Transversus thoracic muscle plane block (TTMPB)
Number of subjects: 39
Study: 34620406

Group type: EXPERIMENTAL
Intervention: Ezetimibe/Simvastatin
Number of subjects: 17999

Group type: COMPARATOR
Intervention: Placebo/Simvastatin
Number of subjects: 17999
Study: 34203181

Group type: EXPERIMENTAL
Intervention: apoE4
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: apoE2
Number of subjects: 0
Study: 33636369

Group type: EXPERIMENTAL
Intervention: Pre-exposure
Number of subjects: 141

Group type: COMPARATOR
Intervention: Overshadowing
Number of subjects: 141
Study: 32256231

Group type: EXPERIMENTAL
Intervention: PST-A method (Polyglot Search Translator)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Manual method
Number of subjects: 16
Study: 35243872

Group type: EXPERIMENTAL
Intervention: hs‐cTnT (high-sensitivity cardiac troponin T)
Number of subjects: 8828

Group type: EXPERIMENTAL
Intervention: NT‐proBNP (N-terminal pro-B-type natriuretic peptide)
Number of subjects: 8828

Group type: EXPERIMENTAL
Intervention: hs‐cTnT and NT‐proBNP in the highest tertile
Number of subjects: 8828

Group type: EXPERIMENTAL
Intervention: Intensive-treatment group
Number of subjects: 8828

Group type: COMPARATOR
Intervention: Standard-treatment group
Number of subjects: 8828
Study: 32567357

Group type: EXPERIMENTAL
Intervention: Shortwave diathermy (10 sessions, 5 sessions/week for 2 weeks)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Placebo shortwave diathermy
Number of subjects: 76
Study: 34984835

Group type: EXPERIMENTAL
Intervention: BFR-trial
Number of subjects: 8

Group type: COMPARATOR
Intervention: CON-trial
Number of subjects: 8
Study: 33899216

Group type: EXPERIMENTAL
Intervention: Electronic point‐of‐care decision support, combination cardiovascular medications (polypills), pharmacy‐based medication adherence program
Number of subjects: 7165

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 7165

Group type: EXPERIMENTAL
Intervention: HealthTracker
Number of subjects: 7165
Study: 32678780

Group type: EXPERIMENTAL
Intervention: Staxi® Medical Chair
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Depot wheelchair
Number of subjects: 23

Group type: COMPARATOR
Intervention: Stryker® Prime TC
Number of subjects: 23
Study: 33725854

Group type: EXPERIMENTAL
Intervention: Mixture of 3 probiotics: Lactobacillus acidophilus, Bifidobacterium bifidum, and Lactobacillus rhamnosus (3×10^9 CFU)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mixture of 8 probiotics: Lactobacillus acidophilus, Bifidobacterium bifidum, Lactobacillus rhamnosus, Lactobacillus paracasei, Bifidobacterium longum, Bifidobacterium lactis, Lactobacillus defensis, Bifidobacterium animallis (8×10^9 CFU)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: All groups (3 probiotics, 8 probiotics, placebo)
Number of subjects: 0
Study: 32749863

Group type: EXPERIMENTAL
Intervention: Oral acetaminophen
Number of subjects: 138

Group type: COMPARATOR
Intervention: Intravenous acetaminophen
Number of subjects: 138
Study: 35590274

Group type: COMPARATOR
Intervention: 8-week exergaming group
Number of subjects: 200

Group type: COMPARATOR
Intervention: 8-week companion group
Number of subjects: 200

Group type: COMPARATOR
Intervention: 5-week companion group
Number of subjects: 200
Study: 34135470

Group type: EXPERIMENTAL
Intervention: Pre-diagnosis statin use
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Statin use after diagnosis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Statin use after diagnosis (started after cancer diagnosis)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Statin use after diagnosis (continuing users)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Statin use after diagnosis (for endometrioid cancers)
Number of subjects: 0
Study: 32027744

Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 25
Study: 35889755

Group type: EXPERIMENTAL
Intervention: Curcumin treatment in DM + I/R rats
Number of subjects: 4

Group type: COMPARATOR
Intervention: Citrate buffer (control group)
Number of subjects: 4

Group type: COMPARATOR
Intervention: DM (streptozotocin, 65 mg/k, single dose, i.v.)
Number of subjects: 4

Group type: COMPARATOR
Intervention: DM + I/R (DM rats with renal pedicle clamped for 30 min)
Number of subjects: 4
Study: 34890584

Group type: EXPERIMENTAL
Intervention: snNICUs
Number of subjects: 22081

Group type: COMPARATOR
Intervention: non-snNICUs
Number of subjects: 22081
Study: 32795619

Group type: EXPERIMENTAL
Intervention: Mechanochemical ablation (MOCA)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Endovenous laser ablation (EVLA)
Number of subjects: 117

Group type: COMPARATOR
Intervention: Radiofrequency ablation (RFA)
Number of subjects: 117
Study: 35068018

Group type: EXPERIMENTAL
Intervention: 16F Foley catheter
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: 22F Foley catheter
Number of subjects: 127

Group type: EXPERIMENTAL
Intervention: 28F Foley catheter
Number of subjects: 127
Study: 32537348

Group type: EXPERIMENTAL
Intervention: ALGINATE
Number of subjects: 95

Group type: COMPARATOR
Intervention: NPWT
Number of subjects: 95

Group type: COMPARATOR
Intervention: ALGINATE vs NPWT
Number of subjects: 95
Study: 36484188

Group type: EXPERIMENTAL
Intervention: Pricking‐cupping therapy
Number of subjects: 70

Group type: COMPARATOR
Intervention: Acupuncture‐cupping therapy
Number of subjects: 70
Study: 32624400

Group type: EXPERIMENTAL
Intervention: Pre-incisional TAP block (n=40)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Post-incisional TAP block (n=40)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 80
Study: 32933955

Group type: EXPERIMENTAL
Intervention: RTS,S/AS01E vaccine and four courses of SMC SP+AQ
Number of subjects: 5920

Group type: COMPARATOR
Intervention: SMC SP+AQ placebo
Number of subjects: 5920

Group type: COMPARATOR
Intervention: Rabies vaccine in year 1 and hepatitis A vaccine in years 2 and 3 with four cycles of SMC SP+AQ
Number of subjects: 5920
Study: 34476770

Group type: EXPERIMENTAL
Intervention: Adjunctive Brivaracetam (BRV)
Number of subjects: 1029

Group type: EXPERIMENTAL
Intervention: Adjunctive Brivaracetam (BRV) in LEV-naive patients
Number of subjects: 1029

Group type: EXPERIMENTAL
Intervention: Adjunctive Brivaracetam (BRV) in patients with prior LEV use and discontinuation due to insufficient efficacy
Number of subjects: 1029

Group type: EXPERIMENTAL
Intervention: Adjunctive Brivaracetam (BRV) in patients with prior LEV use and discontinuation due to AEs
Number of subjects: 1029

Group type: COMPARATOR
Intervention: Adjunctive Brivaracetam (BRV) with strong enzyme-inducing antiseizure medications (EiASMs)
Number of subjects: 1029

Group type: EXPERIMENTAL
Intervention: Adjunctive Brivaracetam (BRV) with sodium channel blockers (SCBs)
Number of subjects: 1029
Study: 36116089

Group type: EXPERIMENTAL
Intervention: Ultrasonography guidance
Number of subjects: 621

Group type: COMPARATOR
Intervention: No ultrasonography guidance
Number of subjects: 621
Study: 34945780

Group type: EXPERIMENTAL
Intervention: Deep neuromuscular blockade (NMB)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Moderate neuromuscular blockade (NMB)
Number of subjects: 0
Study: 32389507

Group type: EXPERIMENTAL
Intervention: Secondhand smoking most of their work time
Number of subjects: 49569

Group type: EXPERIMENTAL
Intervention: Secondhand smoking most of their adult living time
Number of subjects: 49569

Group type: EXPERIMENTAL
Intervention: Secondhand smoking most of the adult time
Number of subjects: 49569
Study: 35941737

Group type: EXPERIMENTAL
Intervention: DMPA-IM
Number of subjects: 58

Group type: COMPARATOR
Intervention: Cu-IUD
Number of subjects: 58

Group type: COMPARATOR
Intervention: LNG implant
Number of subjects: 58
Study: 33597044

Group type: EXPERIMENTAL
Intervention: School teacher training programme to teach the '.b' programme as part of compulsory classroom teaching.
Number of subjects: 2000
Study: 32703227

Group type: EXPERIMENTAL
Intervention: Carapa procera
Number of subjects: 336

Group type: EXPERIMENTAL
Intervention: Lophira lanceolata
Number of subjects: 336

Group type: EXPERIMENTAL
Intervention: Pentadesma butyracea
Number of subjects: 336

Group type: EXPERIMENTAL
Intervention: General population preferences
Number of subjects: 336

Group type: EXPERIMENTAL
Intervention: Tree selection for oil-seed collection
Number of subjects: 336

Group type: EXPERIMENTAL
Intervention: Conservation actions
Number of subjects: 336
Study: 35506932

Group type: EXPERIMENTAL
Intervention: Pneumatic partial weight support treadmill
Number of subjects: 109
Study: 34677083

Group type: EXPERIMENTAL
Intervention: 2D HD
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 3D HD
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 4K HD
Number of subjects: 45
Study: 33170481

Group type: EXPERIMENTAL
Intervention: Integrated symptom management and lifestyle intervention (SMLI)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Attention control
Number of subjects: 45
Study: 32958408

Group type: EXPERIMENTAL
Intervention: High-intensity interval training (HIIT): 4 sets of 4 minutes at 80%–90% V̇O2 reserve, alternating with 3 minutes at 50%–60% V̇O2 reserve
Number of subjects: 21

Group type: COMPARATOR
Intervention: Moderate-intensity continuous training (MICT): 28 minutes continuously at 50%–60% V̇O2 reserve
Number of subjects: 21
Study: 35941831

Group type: EXPERIMENTAL
Intervention: Orthokeratology lenses (OKL)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Single-vision spectacles (SVS)
Number of subjects: 49
Study: 33188886

Group type: EXPERIMENTAL
Intervention: pecavaptan 30 mg/d
Number of subjects: 571

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 571

Group type: EXPERIMENTAL
Intervention: pecavaptan or diuretics as monotherapy
Number of subjects: 571
Study: 36472360

Group type: EXPERIMENTAL
Intervention: Cognitive Restructuring (CR) intervention
Number of subjects: 137

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 137
Study: 33446347

Group type: EXPERIMENTAL
Intervention: Well-being intervention derived from Well-Being Therapy (WBT)
Number of subjects: 0
Study: 32757999

Group type: EXPERIMENTAL
Intervention: Pericapsular injection of 30 mL of ropivacaine and 12 mg of morphine
Number of subjects: 64

Group type: COMPARATOR
Intervention: Lumbar plexus blockade
Number of subjects: 64
Study: 34843023

Group type: EXPERIMENTAL
Intervention: Combination group (0.3% and 0.15% HA)
Number of subjects: 76

Group type: COMPARATOR
Intervention: 0.3% HA group
Number of subjects: 76

Group type: COMPARATOR
Intervention: 0.15% HA group
Number of subjects: 76
Study: 33025865

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 34068170

Group type: EXPERIMENTAL
Intervention: Cocoa flavanol (450‐500 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo control
Number of subjects: 12
Study: 34035391

Group type: EXPERIMENTAL
Intervention: Functional CYP2D6
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Non-functional CYP2D6 (poor metabolizers)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Other CYPs
Number of subjects: 81
Study: 36471349

Group type: EXPERIMENTAL
Intervention: Personalised biopsychosocial rehabilitation programme of 14 weeks
Number of subjects: 112

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 112
Study: 33306118

Group type: EXPERIMENTAL
Intervention: Unauthorized immigrants
Number of subjects: 47199

Group type: EXPERIMENTAL
Intervention: Authorized immigrants
Number of subjects: 47199

Group type: EXPERIMENTAL
Intervention: US-born individuals
Number of subjects: 47199
Study: 33570985

Group type: EXPERIMENTAL
Intervention: School-based intervention focused on increasing adolescents' ethnic-racial identity (ERI) exploration
Number of subjects: 218

Group type: COMPARATOR
Intervention: Attention control
Number of subjects: 218
Study: 32494981

Group type: EXPERIMENTAL
Intervention: S-1 plus cisplatin (SP)
Number of subjects: 50

Group type: COMPARATOR
Intervention: capecitabine plus cisplatin (XP)
Number of subjects: 50
Study: 35876124

Group type: EXPERIMENTAL
Intervention: Acarbose treatment
Number of subjects: 6522

Group type: EXPERIMENTAL
Intervention: Cardiovascular events (MI, stroke, heart failure, angina)
Number of subjects: 6522
Study: 33064299

Group type: EXPERIMENTAL
Intervention: Inosine 5'-monophosphate (IMP)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study: 32231103

Group type: EXPERIMENTAL
Intervention: PLANT (Animal 30%/plant 70%)
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: 50/50 (Animal 50%/plant 50%)
Number of subjects: 136

Group type: COMPARATOR
Intervention: ANIMAL (Animal 70%/plant 30%)
Number of subjects: 136
Study: 35199973

Group type: EXPERIMENTAL
Intervention: Buprenorphine in adductor canal block (bupACB)
Number of subjects: 385

Group type: EXPERIMENTAL
Intervention: Buprenorphine in femoral nerve block (bupFNB)
Number of subjects: 385

Group type: EXPERIMENTAL
Intervention: Dexamethasone in adductor canal block (dexACB)
Number of subjects: 385

Group type: EXPERIMENTAL
Intervention: Dexamethasone in femoral nerve block (dexFNB)
Number of subjects: 385

Group type: COMPARATOR
Intervention: Overall pain control
Number of subjects: 385

Group type: COMPARATOR
Intervention: Rescue analgesia needed
Number of subjects: 385

Group type: COMPARATOR
Intervention: Percentage of timepoints without pain
Number of subjects: 385

Group type: COMPARATOR
Intervention: Mean VRS<inf>11</inf> score
Number of subjects: 385

Group type: COMPARATOR
Intervention: Use of intravenous morphine
Number of subjects: 385
Study: 34106458

Group type: EXPERIMENTAL
Intervention: Fluoride varnish applications every 6 months
Number of subjects: 0

Group type: COMPARATOR
Intervention: No fluoride varnish applications
Number of subjects: 0
Study: 32651634

Group type: EXPERIMENTAL
Intervention: INTERMITTENT (4 meals per day separated by 5 hours)
Number of subjects: 20

Group type: COMPARATOR
Intervention: CONTINUOUS (24 hours day-1 at a constant rate)
Number of subjects: 20

Group type: COMPARATOR
Intervention: CONTINUOUS
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: INTERMITTENT
Number of subjects: 20
Study: 34111772

Group type: EXPERIMENTAL
Intervention: Al-Anon Intensive Referral (AIR)
Number of subjects: 31
Study: 33435475

Group type: EXPERIMENTAL
Intervention: Gum Arabic (GA) 20 g daily for 12 weeks
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo (1 g pectin)
Number of subjects: 80
Study: 34255069

Group type: EXPERIMENTAL
Intervention: Trp-3 (3 g)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Trp-1.5 (1.5 g)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 25
Study: 34344121

Group type: EXPERIMENTAL
Intervention: Compound wild chrysanthemum eye masks
Number of subjects: 112

Group type: COMPARATOR
Intervention: Eye mask simulator (control)
Number of subjects: 112
Study: 33097092

Group type: COMPARATOR
Intervention: FEC → Doc
Number of subjects: 3754

Group type: EXPERIMENTAL
Intervention: FEC → Doc/Gem
Number of subjects: 3754
Study: 35834777

Group type: EXPERIMENTAL
Intervention: Active maintenance olaparib (300 mg twice daily)
Number of subjects: 154

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 154
Study: 34158381

Group type: EXPERIMENTAL
Intervention: Higher genetically predicted serum magnesium concentrations
Number of subjects: 79429
Study: 32745703

Group type: EXPERIMENTAL
Intervention: COPE-P intervention
Number of subjects: 384

Group type: COMPARATOR
Intervention: Attention control program
Number of subjects: 384
Study: 34552422

Group type: EXPERIMENTAL
Intervention: Forearm tourniquet for 25 minutes
Number of subjects: 66

Group type: COMPARATOR
Intervention: Upper arm tourniquet for 25 minutes
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Forearm tourniquet with immediate deflation (<25 minutes)
Number of subjects: 66
Study: 32340906

Group type: EXPERIMENTAL
Intervention: IANB with angulated needle approach (ANA)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Indirect IANB
Number of subjects: 90

Group type: COMPARATOR
Intervention: Direct IANB
Number of subjects: 90
Study: 35122549

Group type: EXPERIMENTAL
Intervention: Metronidazole adjunctive to periodontal surgery
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo adjunctive to periodontal surgery
Number of subjects: 0
Study: 34791813

Group type: EXPERIMENTAL
Intervention: DEX 40 mg on days 1-4 of a 4-week cycle for six cycles
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: DEX 40 mg on days 1-4 of a 4-week cycle for six cycles with ruxolitinib 15 mg BID on days 1-21 of each cycle
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control group (DEX alone)
Number of subjects: 8
Study: 36349498

Group type: EXPERIMENTAL
Intervention: Provider Education + Community Health Worker Support (PE+CHW)
Number of subjects: 1010

Group type: COMPARATOR
Intervention: Provider Education alone (PE)
Number of subjects: 1010
Study: 34446487

Group type: EXPERIMENTAL
Intervention: Multimodal intervention delivered by cancer exercise specialists (CES) for 6 months, including physical activity, basic dietary advice, and psychological support
Number of subjects: 1050

Group type: EXPERIMENTAL
Intervention: Multimodal intervention delivered by CES
Number of subjects: 1050
Study: 33077895

Group type: EXPERIMENTAL
Intervention: Elamipretide (40 mg per day)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 36221362

Group type: EXPERIMENTAL
Intervention: Hypertonic sodium lactate infusion
Number of subjects: 50

Group type: COMPARATOR
Intervention: Mannitol (conventional group)
Number of subjects: 50
Study: 32891977

Group type: EXPERIMENTAL
Intervention: Brief Motivational Intervention (BMI)
Number of subjects: 596

Group type: EXPERIMENTAL
Intervention: BMI with Telephone Booster (BMI + B)
Number of subjects: 596

Group type: COMPARATOR
Intervention: Brief Advice (BA)
Number of subjects: 596
Study: 32771018

Group type: EXPERIMENTAL
Intervention: Multidimensional physical activity feedback using a customised digital system and web-app for 3 months plus five health trainer-led sessions.
Number of subjects: 204

Group type: COMPARATOR
Intervention: Standardised information regarding physical activity (received by all participants).
Number of subjects: 204
Study: 34285011

Group type: EXPERIMENTAL
Intervention: Aflatoxin exposure (measured by AF-albumin adduct levels)
Number of subjects: 374

Group type: COMPARATOR
Intervention: Control (no specific intervention mentioned)
Number of subjects: 374
Study: 33660379

Group type: EXPERIMENTAL
Intervention: Individualized education on self-management (50-min session, one telephone counselling after 8 weeks, maintenance of a self-management diary for 12 weeks)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no specific intervention details provided)
Number of subjects: 60
Study: 32788268

Group type: EXPERIMENTAL
Intervention: Early feeding (unrestricted diet)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Initial fasting and intravenous fluids (control)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Early feeding
Number of subjects: 33
Study: 35696725

Group type: EXPERIMENTAL
Intervention: Nonrestricted low‐fat diet (LFD)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Calorie-restricted (CR) regimens (low‐fat CR, Mediterranean‐style CR, intermittent CR)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Continuously obese mice
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lean control mice
Number of subjects: 0
Study: 33794664

Group type: EXPERIMENTAL
Intervention: Topical ketorolac tromethamine 0.5%
Number of subjects: 33

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 33
Study: 32893392

Group type: EXPERIMENTAL
Intervention: Low dialysate [Na+] levels
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard dialysate [Na+] levels
Number of subjects: 0
Study: 35251940

Group type: EXPERIMENTAL
Intervention: App-based intervention with human guidance
Number of subjects: 356

Group type: COMPARATOR
Intervention: Treatment as usual plus app-based intervention after the active study phase (waitlist control/TAU group)
Number of subjects: 356
Study: 32537847

Group type: EXPERIMENTAL
Intervention: Ramucirumab 8 mg/kg on days 1 and 15 and merestinib 80 mg once daily (QD; 28-day cycle)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 16
Study: 32773628

Group type: EXPERIMENTAL
Intervention: Retrocolic reconstruction
Number of subjects: 212

Group type: COMPARATOR
Intervention: Antecolic reconstruction
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 212
Study: 32203691

Group type: EXPERIMENTAL
Intervention: Levetiracetam
Number of subjects: 462

Group type: EXPERIMENTAL
Intervention: Fosphenytoin
Number of subjects: 462

Group type: EXPERIMENTAL
Intervention: Valproate
Number of subjects: 462

Group type: COMPARATOR
Intervention: Levetiracetam, Fosphenytoin, Valproate
Number of subjects: 462